Nasdaq Stockholm has decided that Biotage AB (publ) will be delisted from Nasdaq Stockholm. The last day of trading in the share will be on Monday, July 21, 2025.
Contacts
Frederic Vanderhaegen, President & CEO
Tel: +41 797600543
frederic.vanderhaegen@biotage.com
About Biotage
Biotage is a global supplier and solutions partner to a wide range of customers within Drug Discovery and Development and Analytical Testing. With expertise in separation and purification technology and leveraging intelligent workflow solutions, the group aims to be the best partner advancing health solutions.
Headquartered in Sweden, Biotage operates globally serving over 80 countries. Biotage is listed on NASDAQ Stockholm (BIOT).
Website: www.biotage.com
© 2025 GlobeNewswire (Europe)